As World Cancer Day approaches on Sunday, February 4th, Adalvo reaffirms its commitment to making a meaningful impact in the fight against cancer. With a focus on oncology, Adalvo continues to advance its mission to develop innovative therapies that improve the lives of individuals affected by cancer.
On this World Cancer Day, Adalvo reflects on its dedication to oncology research and the development of innovative therapies to address various forms of cancer.
Adalvo's commitment to oncology extends across its entire portfolio, with a focus on delivering high-quality and effective treatments. The company is actively engaged in research and development efforts to bring forward innovative solutions that can make a significant difference in cancer patients' lives.
Partner up now!
At Adalvo, there are no half-measures – we are always on target. When your mission is to be faster and stronger than your competitors, you need a winning team driving your vision forward.
arni.baldursson@adalvo.com - Head of Global BD&L
camila.reinoso@adalvo.com - LATAM (exc. Brazil)
marta.puig@adalvo.com - North and South Europe & LATAM
ajish.rajan@adalvo.com – Central & Eastern Europe, Russia & CIS
bruno.alves@adalvo.com - Brazil & MENA
jose.rendueles@adalvo.com- North Europe, APAC, MENA & Israel
marc.nolasco@adalvo.com - Central and Western Europe
paulo.rodriguez@adalvo.com – Europe
supreet.sharma@adalvo.com – UK/Ireland, North America & South Africa
Click on your preferred Business Partner and get in touch today!